 |
인쇄하기
취소
|
Green Cross develops fourth natural medicine
Green Cross Corp. says its natural drug for the treatment of osteoarthritis drug ‘Shinbaro’ has been recently approved by the Korea Food and Drug Administration.
The company said Shinbaro is Korea’s fourth homegrown natural medicine, which have been developed through the intensive studies for seven years under the collaboration with the academia.
Shinbaro has been shown to exhibit anti-in...
The company said Shinbaro is Korea’s fourth homegrown natural medicine, which have been developed through the intensive studies for seven years under the collaboration with the academia.
Shinbaro has been shown to exhibit anti-in...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.